• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于蛋白质递送的可生物降解聚(酯-共-内酯)微粒的评估

Evaluation of biodegradable polyester-co-lactone microparticles for protein delivery.

作者信息

Tawfeek Hesham M, Khidr Sayed H, Samy Eman M, Ahmed Sayed M, Gaskell Elsie E, Hutcheon Gillian A

机构信息

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University , Liverpool , UK and.

出版信息

Drug Dev Ind Pharm. 2014 Sep;40(9):1213-22. doi: 10.3109/03639045.2013.814060. Epub 2013 Jul 15.

DOI:10.3109/03639045.2013.814060
PMID:23855737
Abstract

Abstract Poly(glycerol adipate-co-ω-pentadecalactone) (PGA-co-PDL) was previously evaluated for the colloidal delivery of α-chymotrypsin. In this article, the effect of varying polymer molecular weight (MW) and chemistry on particle size and morphology; encapsulation efficiency; in vitro release; and the biological activity of α-chymotrypsin (α-CH) and lysozyme (LS) were investigated. Microparticles were prepared using emulsion solvent evaporation and evaluated by various methods. Altering the MW or monomer ratio of PGA-co-PDL did not significantly affect the encapsulation efficiency and overall poly(1,3-propanediol adipate-co-ω-pentadecalactone) (PPA-co-PDL) demonstrated the highest encapsulation efficiency. In vitro release varied between polymers, and the burst release for α-CH-loaded microparticles was lower when a higher MW PGA-co-PDL or more hydrophobic PPA-co-PDL was used. The results suggest that, although these co-polyesters could be useful for protein delivery, little difference was observed between the different PGA-co-PDL polymers and PPA-co-PDL generally provided a higher encapsulation and slower release of enzyme than the other polymers tested.

摘要

摘要 聚(己二酸甘油酯 - 共 - ω - 十五内酯)(PGA - co - PDL)先前已被评估用于α - 胰凝乳蛋白酶的胶体递送。在本文中,研究了聚合物分子量(MW)和化学组成的变化对粒径和形态、包封效率、体外释放以及α - 胰凝乳蛋白酶(α - CH)和溶菌酶(LS)生物活性的影响。使用乳液溶剂蒸发法制备微粒,并通过各种方法进行评估。改变PGA - co - PDL的分子量或单体比例对包封效率没有显著影响,总体而言聚(1,3 - 丙二醇己二酸酯 - 共 - ω - 十五内酯)(PPA - co - PDL)表现出最高的包封效率。聚合物之间的体外释放情况各不相同,当使用较高分子量的PGA - co - PDL或更疏水的PPA - co - PDL时,负载α - CH的微粒的突释较低。结果表明,尽管这些共聚酯可用于蛋白质递送,但在不同的PGA - co - PDL聚合物之间观察到的差异不大,并且与测试的其他聚合物相比,PPA - co - PDL通常具有更高的酶包封率和更慢的释放速度。

相似文献

1
Evaluation of biodegradable polyester-co-lactone microparticles for protein delivery.用于蛋白质递送的可生物降解聚(酯-共-内酯)微粒的评估
Drug Dev Ind Pharm. 2014 Sep;40(9):1213-22. doi: 10.3109/03639045.2013.814060. Epub 2013 Jul 15.
2
Encapsulation and release of alpha-chymotrypsin from poly(glycerol adipate-co-omega-pentadecalactone) microparticles.α-胰凝乳蛋白酶在聚(己二酸甘油酯-共-ω-十五内酯)微粒中的包封与释放
J Microencapsul. 2008 May;25(3):187-95. doi: 10.1080/02652040701848775.
3
Dry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriers.采用新型聚乙二醇-共聚酯微粒载体干粉吸入大分子药物。
Int J Pharm. 2013 Jan 30;441(1-2):611-9. doi: 10.1016/j.ijpharm.2012.10.036. Epub 2012 Nov 1.
4
Evaluation of PEG and mPEG-co-(PGA-co-PDL) microparticles loaded with sodium diclofenac.载双氯芬酸钠的 PEG 和 mPEG-co-(PGA-co-PDL) 微球评价。
Saudi Pharm J. 2013 Oct;21(4):387-97. doi: 10.1016/j.jsps.2012.11.006.
5
Pulmonary Delivery of Proteins Using Nanocomposite Microcarriers.使用纳米复合微载体进行蛋白质的肺部递送。
J Pharm Sci. 2015 Dec;104(12):4386-4398. doi: 10.1002/jps.24681. Epub 2015 Oct 27.
6
Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated with Eudragit L100-55 from fast disintegrating tablets.载有吲哚美辛的聚乙醇酸-共-聚-D-乳酸微粒用Eudragit L100-55包衣后通过快速崩解片实现结肠给药。
Int J Pharm. 2017 Oct 5;531(1):80-89. doi: 10.1016/j.ijpharm.2017.08.069. Epub 2017 Aug 15.
7
Poly(glycerol adipate-co-ω-pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery.聚(己二酸甘油酯-co-ω-十五内酯)喷雾干燥微球作为肺部给药的缓释载体。
Pharm Res. 2011 Sep;28(9):2086-97. doi: 10.1007/s11095-011-0433-6. Epub 2011 May 2.
8
Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.载溶菌酶脂质-聚合物杂化纳米粒:制备、表征及胶体稳定性评估
Drug Dev Ind Pharm. 2016 Nov;42(11):1865-76. doi: 10.1080/03639045.2016.1180392. Epub 2016 Apr 28.
9
The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.影响聚己内酯微球形态和包封药物释放的参数。
Int J Pharm. 2015 Oct 15;494(1):152-66. doi: 10.1016/j.ijpharm.2015.07.068. Epub 2015 Jul 30.
10
Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.聚丁二酸丁二醇酯、聚丁二酸丁二醇酯-己二酸酯和聚对苯二甲酸丁二醇酯-己二酸酯的可生物降解微胶囊作为药物包封系统的性能。
Colloids Surf B Biointerfaces. 2011 Jun 1;84(2):498-507. doi: 10.1016/j.colsurfb.2011.02.005. Epub 2011 Mar 3.

引用本文的文献

1
Polymers as Encapsulating Agents and Delivery Vehicles of Enzymes.聚合物作为酶的包封剂和递送载体。
Polymers (Basel). 2021 Nov 23;13(23):4061. doi: 10.3390/polym13234061.